Development of a Moloney murine leukemia virus-based pseudotype anti-HIV assay suitable for accurate and rapid evaluation of HIV entry inhibitors (Q40255176)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 July 2006

Language	Label	Description	Also known as
English	Development of a Moloney murine leukemia virus-based pseudotype anti-HIV assay suitable for accurate and rapid evaluation of HIV entry inhibitors	scientific article published on 14 July 2006

Statements

scholarly article

1 reference

Europe PubMed Central

18 September 2017

Development of a Moloney murine leukemia virus-based pseudotype anti-HIV assay suitable for accurate and rapid evaluation of HIV entry inhibitors (English)

1 reference

Europe PubMed Central

18 September 2017

murine leukemia virus

object named as

murine leukemia virus

1 reference

based on heuristic

inferred from title

Moloney murine leukemia virus

object named as

Moloney murine leukemia virus

1 reference

based on heuristic

inferred from title

author name string

Eva Chan

1

1 reference

Europe PubMed Central

18 September 2017

Gabrielle Heilek-Snyder

2

1 reference

Europe PubMed Central

18 September 2017

Nick Cammack

3

1 reference

Europe PubMed Central

18 September 2017

Surya Sankuratri

4

1 reference

Europe PubMed Central

18 September 2017

Changhua Ji

5

1 reference

Europe PubMed Central

18 September 2017

publication date

14 July 2006

1 reference

Europe PubMed Central

18 September 2017

Journal of Biomolecular Screening

1 reference

Europe PubMed Central

18 September 2017

11

1 reference

Europe PubMed Central

18 September 2017

6

1 reference

Europe PubMed Central

18 September 2017

652-663

1 reference

Europe PubMed Central

18 September 2017

Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Mechanisms of viral membrane fusion and its inhibition

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Assessing chemokine co-receptor usage in HIV

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Prospects of HIV-1 entry inhibitors as novel therapeutics

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Enfuvirtide: the first HIV fusion inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS.

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Development of a safe and rapid neutralization assay using murine leukemia virus pseudotyped with HIV type 1 envelope glycoprotein lacking the cytoplasmic domain

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

A vector system for introducing foreign HIV-1 env genes and pseudotyping of MuLV particles with the recombinant HIV-1 envelope proteins for anti-HIV-1 assay

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Development of a novel dual CCR5-dependent and CXCR4-dependent cell-cell fusion assay system with inducible gp160 expression

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

New reporter cell lines to study macrophage-tropic HIV envelope protein-mediated cell-cell fusion

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Retroviral-mediated gene transfer into hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Retroviral pseudotypes produced by rescue of a moloney murine leukemia virus vector by C-type, but not D-type, retroviruses

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Budding of rabies virus particles in the absence of the spike glycoprotein

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor.

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Domains in the simian immunodeficiency virus gp41 cytoplasmic tail required for envelope incorporation into particles

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer.

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4

1 reference

https://api.crossref.org/works/10.1177%2F1087057106288881

21 January 2018

Identifiers

10.1177/1087057106288881

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40255176&oldid=1891167159"